ArticleIn vivo (Athens, Greece)

Association Between Renal Adverse Effects and Mortality in Patients With Hepatocellular Carcinoma Treated With Lenvatinib.

Yoshinosuke Shimamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.